Revision as of 09:01, 10 August 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{chembox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report [[Wikipedia_talk:Wi← Previous edit |
Latest revision as of 02:07, 18 May 2024 edit undo116.98.218.118 (talk)No edit summaryTag: Visual edit |
(39 intermediate revisions by 25 users not shown) |
Line 1: |
Line 1: |
|
{{chembox |
|
{{chembox |
|
|
| Verifiedfields = changed |
⚫ |
| verifiedrevid = 444023748 |
|
|
|
| Watchedfields = changed |
|
| ImageFile = Neu5NH2.png |
|
|
⚫ |
| verifiedrevid = 444024786 |
⚫ |
| ImageSize = |
|
|
| ImageFile1 = Neuraminic-acid-3D-balls.png |
|
| ImageFile = Beta Neuraminic acid.svg |
|
⚫ |
| ImageSize = |
⚫ |
| IUPACName = (4S,5R,6R,7S,8R)-5-amino-4,6,7,8,9-<br>pentahydroxy-2-oxo-nonanoic acid |
|
|
|
| ImageFile1 = Neuraminic-acid-side-based-on-similar-xtals-Mercury-3D-balls.png |
⚫ |
| OtherNames = |
|
|
|
| IUPACName = 5-Amino-3,5-dideoxy-{{sm|d}}-''glycero''-{{sm|d}}-''galacto''-non-2-ulosonic acid |
⚫ |
| Section1 = {{Chembox Identifiers |
|
|
⚫ |
| OtherNames = |
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
|
⚫ |
| SystematicName = (4''S'',5''R'',6''R'',7''S'',8''R'')-5-Amino-4,6,7,8,9-<wbr>pentahydroxy-2-oxononanoic acid |
|
⚫ |
| Section1 = {{Chembox Identifiers |
|
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 447972 |
|
| ChemSpiderID = 447972 |
|
| InChI = 1/C9H17NO8/c10-5-3(12)1-9(17,8(15)16)18-7(5)6(14)4(13)2-11/h3-7,11-14,17H,1-2,10H2,(H,15,16)/t3-,4+,5+,6+,7+,9-/m0/s1 |
|
| InChI = 1/C9H17NO8/c10-5-3(12)1-9(17,8(15)16)18-7(5)6(14)4(13)2-11/h3-7,11-14,17H,1-2,10H2,(H,15,16)/t3-,4+,5+,6+,7+,9-/m0/s1 |
Line 15: |
Line 18: |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = CERZMXAJYMMUDR-YOQZMRDMSA-N |
|
| StdInChIKey = CERZMXAJYMMUDR-YOQZMRDMSA-N |
|
⚫ |
| CASNo_Ref = {{cascite|correct|??}} |
|
| CASNo = 114-04-5 |
|
| CASNo = 114-04-5 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
⚫ |
| PubChem = 513472 |
|
|
|
| UNII = L4866H38XY |
⚫ |
| ChEBI_Ref = {{ebicite|correct|EBI}} |
|
|
⚫ |
| PubChem = 513472 |
|
|
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL = 165084 |
|
|
| ChEMBL2_Ref = {{ebicite|changed|EBI}} |
|
|
| ChEMBL2 = 1234621 |
|
|
| ChEBI_Ref = {{ebicite|correct|EBI}} |
|
| ChEBI = 49022 |
|
| ChEBI = 49022 |
|
| SMILES = O=C(O)1(O)O((O)(O)CO)(N)(O)C1 |
|
| SMILES = O=C(O)1(O)O((O)(O)CO)(N)(O)C1 |
|
| MeSHName = Neuraminic+Acids |
|
| MeSHName = Neuraminic+Acids |
|
}} |
|
}} |
|
| Section2 = {{Chembox Properties |
|
| Section2 = {{Chembox Properties |
|
| Formula = C<sub>9</sub>H<sub>17</sub>N<sub>1</sub>O<sub>8</sub> |
|
| Formula = C<sub>9</sub>H<sub>17</sub>NO<sub>8</sub> |
|
| MolarMass = 267.233 g/mol |
|
| MolarMass = 267.233 g/mol |
|
| Appearance = |
|
| Appearance = |
|
| Density = |
|
| Density = |
|
| MeltingPt = |
|
| MeltingPt = |
|
| BoilingPt = |
|
| BoilingPt = |
|
}} |
|
}} |
|
| Section3 = {{Chembox Hazards |
|
| Section3 = {{Chembox Hazards |
|
| Solubility = |
|
| MainHazards = |
|
| MainHazards = |
|
| FlashPt = |
|
| FlashPt = |
|
| AutoignitionPt = |
|
| Autoignition = |
|
|
}} |
|
}} |
|
}} |
|
}} |
|
|
] of neuraminic acid in its ] form.]] |
⚫ |
'''Neuraminic acid''' (5-amino-3,5-dideoxy-D-''glycero''-D-''galacto''-non-2-ulosonic acid) is a 9-carbon ], a derivative of a ]. Neuraminic acid may be visualized as the product of an ] product of ] and D-] (2-amino-2-deoxy-mannose). Neuraminic acid does not occur naturally, but many of its derivatives are found widely distributed in animal tissues and in bacteria, especially in ]s and ]s. The ''N''- or ''O''-substituted derivatives of neuraminic acid are collectively known as ]s, the predominant form in mammalian cells being ]. The amino group bears either an acetyl or a glycolyl group. The hydroxyl substituents may vary considerably: Acetyl, lactyl, methyl, sulfate and phosphate groups have been found. |
|
|
|
'''Neuraminic acid''' (5-amino-3,5-dideoxy-<small>D</small>-''glycero''-<small>D</small>-''galacto''-non-2-ulosonic acid) is an ] (in particular ]) ] with a backbone formed by nine ]s.<ref name=":0">{{Citation|last=Blanco|first=Antonio|title=Chapter 4 - Carbohydrates|date=2017-01-01|url=http://www.sciencedirect.com/science/article/pii/B9780128035504000045|work=Medical Biochemistry|pages=73–97|editor-last=Blanco|editor-first=Antonio|publisher=Academic Press|language=en|doi=10.1016/b978-0-12-803550-4.00004-5|isbn=978-0-12-803550-4|access-date=2020-12-16|last2=Blanco|first2=Gustavo|editor2-last=Blanco|editor2-first=Gustavo}}</ref> Although 9-carbon sugars do not occur naturally, neuraminic acid may be regarded as a theoretical 9-carbon ] in which the first link of the chain (the –CH<sub>2</sub>OH at ]) is ] into a ] (–C(=O)OH), the ] at position 3 is deoxidised (oxygen is removed from it), and the hydroxyl group at position 5 is substituted with an ] (–NH<sub>2</sub>). Neuraminic acid may also be visualized as the product of an ] of ] and <small>D</small>-] (2-amino-2-deoxy-mannose).<ref name=":0" /> |
|
|
|
|
|
⚫ |
Neuraminic acid does not occur naturally, but many of its derivatives are found widely distributed in animal tissues and in bacteria, especially in ]s and ]s. The ''N''- or ''O''-substituted derivatives of neuraminic acid are collectively known as ]s, the predominant form in mammalian cells being ]. The amino group bears either an acetyl or a glycolyl group. The hydroxyl substituents may vary considerably: acetyl, lactyl, methyl, sulfate and phosphate groups have been found. |
⚫ |
The name "neuraminic acid" was introduced by German scientist E. Klenk in 1941, in reference to the brain lipids from which it was derived as a cleavage product.<ref>Klenk, E. 1941. Neuraminsäure, das Spaltprodukt eines neuen Gehirnlipoids. ''Zeitschr. f. Physiol. Chem.'' 1941; 268:50-58.</ref>. |
|
|
|
|
|
|
⚫ |
The name "neuraminic acid" was introduced by German scientist E. Klenk in 1941, in reference to the brain lipids from which it was derived as a cleavage product.<ref>Klenk, E. 1941. Neuraminsäure, das Spaltprodukt eines neuen Gehirnlipoids. ''Zeitschr. f. Physiol. Chem.'' 1941; 268:50-58.</ref> |
⚫ |
The symbol commonly used for neuraminic acid is '''Neu''', and the residue is typically found with additional chemical modifications in biological systems. As a family, these residues are known as ]. For example, N-acetyl-neuraminic acid, Neu5Ac, is typical in human glycoproteins. |
|
|
|
|
|
|
⚫ |
The ] symbol used for neuraminic acid is '''Neu''', and the residue is typically found with additional chemical modifications in biological systems. As a family, these residues are known as ]. For example, ''N''-acetylneuraminic acid, Neu5Ac, is typical in human glycoproteins. |
⚫ |
Among their many biological functions, these structures are substrates for ] enzymes which cleave neuraminic acid residues. Human ] viruses have a neuraminidase enzyme, signified in the name "H#N#", where the H refers to an ] of ] and N refers to an isoform of ]. |
|
|
|
|
|
⚫ |
Among their many biological functions, these structures are substrates for ] enzymes which cleave neuraminic acid residues. Human ] viruses have a neuraminidase enzyme, signified in the name "H#N#", where the H refers to an ] of ] and N refers to an isoform of ]. |
|
|
|
|
|
==See also== |
|
==See also== |
⚫ |
* ] |
|
|
* ] |
|
* ] |
|
⚫ |
* ] |
|
|
* ] |
|
|
|
|
|
==References and notes== |
|
==References== |
|
{{reflist}} |
|
{{reflist}} |
|
|
|
|
|
{{Carbohydrates}} |
|
|
|
|
|
] |
|
] |
|
|
] |
|
] |
|
] |
|
] |
|
|
|
|
|
] |
|
|
] |
|
|
] |
|